Using data from the NIMH-sponsored RAISE-ETP trial, this study examines socioeconomic barriers to the effec- tive provision of psychiatric care. RAISE investigators found modest bene?ts of an early-intervention program for patients with ?rst-episode psychosis. Our preliminary analysis suggests a large and statistically signi?cant gap in which only high-SES patients bene?tted from the intervention. We will examine possible explanations for this pattern, including SES differences in initial mental health, stigma, treatment adherence, cognition, substance abuse, and economic empowerment. Finally we will quantify the contribution of this pattern for the SES gap in mental health. This inquiry is distinct from any analysis that the RAISE investigators have proposed or carried out.
This study uses data from the RAISE-ETP trial to examine the socioeconomic barriers to effective schizophrenia treatment. It considers the channels through which SES may moderate the impact of care and quanti?es the contribution of this channel to health inequality. This inquiry will explore a previously-unexamined source of mental health disparities.
